At a Glance
| 5-Hydroxytryptophan | D-Serine | |
|---|---|---|
| Class | Nootropic | Nootropic, NMDA enhancer |
| Common Dose (oral) | 100–300 mg | 1000–2000 mg |
| Total Duration | — | 0.5–1.5 hrs |
| Routes | oral | Oral |
5-Hydroxytryptophan, a Nootropic, and D-Serine, a Nootropic, NMDA enhancer, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. 5-Hydroxytryptophan is classified as a Nootropic while D-Serine is a Nootropic, NMDA enhancer, meaning they approach altered states through different pharmacological mechanisms. They share 0 documented effects in common, with 9 effects unique to 5-Hydroxytryptophan and 4 unique to D-Serine. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 5-Hydroxytryptophan | D-Serine | |
|---|---|---|
| Class | Nootropic | Nootropic, NMDA enhancer |
| Common Dose (oral) | 100–300 mg | 1000–2000 mg |
| Total Duration | — | 0.5–1.5 hrs |
| Routes | oral | Oral |
| Effects |
| 9 documented |
| 4 documented |
| Level | 5-Hydroxytryptophan | D-Serine |
|---|---|---|
| Threshold | 25 mg | — mg |
| Light | 50–100 mg | 500–1000 mg |
| Common | 100–300 mg | 1000–2000 mg |
| Strong | 300–500 mg | 2000–4000 mg |
| Heavy | 500 mg | 8000 mg |
5-Hydroxytryptophan
D-Serine
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.